Accenture and Biogen have developed a first-of-a-kind quantum-enabled molecular comparison app designed to speed up drug discovery for complex neurological conditions such as MS, Alzheimer’s, Parkinson’s and Lou Gehrig’s disease. Researchers at Accenture Labs collaborated with 1QBit to create the new application which enhances Biogen’s existing molecule comparison method with quantum capabilities.Molecular comparison is a crucial part of early-phase drug design and discovery, and involves
Read More
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Footer
